Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Anticancer Agents Med Chem. 2021;21(14):1774-1782. doi: 10.2174/1871520621666201207094416.
Natural products and their molecular frameworks have been explored as invaluable sources of inspiration for drug design by means of structural modification, computer-aided drug design, and so on. Scopoletin extracting from multiple herbs exhibits potential anti-cancer activity in vitro and in vivo without toxicity towards normal cells.
The study aims to obtain new scopoletin derivatives with enhanced anti-cancer activity. We performed chemical structure modification and researched the mechanism of anti-tumor activity.
In this study, we considered scopoletin as a lead compound, designed and synthesized a series of scopoletin derivatives via introducing different heterocyclic fragments, and their chemical structures were characterized by NMR spectra (H NMR and C NMR) and HRMS(ESI). The antiproliferative activity of target compounds in four cancer cell lines (MDA-MB-231, MCF-7, HepG2, and A549) was determined by the MTT assay. Compound 11b was treated with Ac-cys under different reaction conditions to explore the thiol addition activity of it. The Annexin V/PI and JC-1 staining assay were performed to investigate the anti-tumor mechanism of 11b.
Novel compounds 8a-h and 11a-h derivatives of scopoletin were synthesized. Most of the target compounds exhibited enhanced antiproliferative activity against different cancer cells and reduced toxicity towards normal cells. In particular, 11b displayed the optimal antitumor ability against breast cancer MDA-MB- 231 cells with an IC value of 4.46 μM. Compound 11b also cannot react with Ac-cys under the experimental condition. When treated with 11b for 24 h, the total apoptotic cells increased from 10.8% to 79.3%. Besides, 11b induced the depolarization of mitochondrial membrane potential.
Compound 11b was more active than other derivatives, indicating that the introduction of thiophene fragment was beneficial for the enhancement of antitumor effect, and it was also not an irreversible inhibitor based on the result that the α, β-unsaturated ketones of 11b cannot undergo Michael addition reactions with Accys. Furthermore, studies on the pharmacological mechanism showed that 11b induced mitochondrial depolarization and apoptosis, which indicated that 11b killed cancer cells via a mitochondrial apoptotic pathway. Therefore, in-depth research and structure optimization of this compound is warranted.
天然产物及其分子结构一直被探索为药物设计的宝贵资源,可通过结构修饰、计算机辅助药物设计等方法进行。从多种草药中提取的花椒毒素在体外和体内表现出潜在的抗癌活性,对正常细胞没有毒性。
本研究旨在获得具有增强抗癌活性的新型花椒毒素衍生物。我们进行了化学结构修饰,并研究了其抗肿瘤活性的机制。
在这项研究中,我们将花椒毒素视为先导化合物,通过引入不同的杂环片段设计并合成了一系列花椒毒素衍生物,并通过 NMR 谱(H NMR 和 C NMR)和高分辨率质谱(HRMS(ESI))对其化学结构进行了表征。采用 MTT 法测定目标化合物在四种癌细胞系(MDA-MB-231、MCF-7、HepG2 和 A549)中的增殖抑制活性。在不同反应条件下用 Ac-cys 处理化合物 11b,以研究其硫醇加成活性。采用 Annexin V/PI 和 JC-1 染色法研究 11b 的抗肿瘤机制。
合成了花椒毒素的新型化合物 8a-h 和 11a-h 衍生物。大多数目标化合物对不同癌细胞的增殖抑制活性增强,对正常细胞的毒性降低。特别是化合物 11b 对乳腺癌 MDA-MB-231 细胞的抗肿瘤活性最佳,IC 值为 4.46 μM。化合物 11b 在实验条件下也不能与 Ac-cys 反应。用 11b 处理 24 h 后,总凋亡细胞从 10.8%增加到 79.3%。此外,11b 诱导线粒体膜电位去极化。
化合物 11b 比其他衍生物更具活性,表明引入噻吩片段有利于增强抗肿瘤作用,而且根据 11b 的α,β-不饱和酮不能与 Accys 发生迈克尔加成反应的结果,它也不是不可逆抑制剂。此外,药理学机制研究表明,11b 诱导线粒体去极化和细胞凋亡,表明 11b 通过线粒体凋亡途径杀死癌细胞。因此,有必要对该化合物进行深入研究和结构优化。